13F Pro

SEC Form 4 reporting owner

Rote William E.

Rote William E. has filed 20 Form 4 transactions reported between December 24, 2025 and September 16, 2026, as Chief Research Officer of Travere Therapeutics, Inc..

Name as filed: ROTE WILLIAM E.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$14.0M
9 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 16, 2026
transaction date

Roles and reported holdings

  • TVTXTravere Therapeutics, Inc.
    Dec 24, 2025 – Sep 16, 2026

    Chief Research Officer

    Held directly98,197 sh as of Sep 16, 2026 · Form 4

    24 months: $14.0M sold

Transaction history

All 20 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 16, 2026TVTXChief Research OfficerOpen-market saleCode S · direct47,746$3.0M@ $63.61Form 4
Sep 16, 2026TVTXChief Research OfficerOpen-market saleCode S · direct65,104$4.1M@ $63.12Form 4
Sep 16, 2026TVTXChief Research OfficerOption exerciseCode M · direct57,500$1.5M@ $26.88Form 4
Sep 16, 2026TVTXChief Research OfficerOption exerciseCode M · direct55,000$850K@ $15.46Form 4
Sep 16, 2026TVTXChief Research OfficerOption exerciseCode M · direct350$6K@ $17.96Form 4
Sep 15, 2026TVTXChief Research OfficerOpen-market saleCode S · directAlso reported by Dube Eric M270$18K@ $65.31Form 4
Sep 15, 2026TVTXChief Research OfficerOpen-market saleCode S · direct3,000$191K@ $63.65Form 4
Sep 15, 2026TVTXChief Research OfficerOpen-market saleCode S · direct29,021$1.8M@ $62.66Form 4
Sep 15, 2026TVTXChief Research OfficerOpen-market saleCode S · direct63,907$4.0M@ $61.99Form 4
Sep 15, 2026TVTXChief Research OfficerOption exerciseCode M · direct39,650$712K@ $17.96Form 4
Sep 15, 2026TVTXChief Research OfficerOption exerciseCode M · direct39,000$985K@ $25.25Form 4
May 6, 2026TVTXChief Research OfficerOpen-market saleCode S · direct2,763$121K@ $43.95Form 4
May 4, 2026TVTXChief Research OfficerGrant or awardCode A · direct8,500—Form 4
May 4, 2026TVTXChief Research OfficerOption exerciseCode M · direct4,250—Form 4
Apr 22, 2026TVTXChief Research OfficerOpen-market saleCode S · direct9,100$356K@ $39.09Form 4
Apr 13, 2026TVTXChief Research OfficerGrant or awardCode A · direct14,000—Form 4
Feb 3, 2026TVTXChief Research OfficerOpen-market saleCode S · direct12,446$409K@ $32.87Form 4
Jan 31, 2026TVTXChief Research OfficerGrant or awardCode A · direct53,570—Form 4
Jan 31, 2026TVTXChief Research OfficerGrant or awardCode A · direct20,090—Form 4
Dec 24, 2025TVTXChief Research OfficerOption exerciseCode M · direct60,000$1.2M@ $20.61Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.